NCT03294395View on ClinicalTrials.gov

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea

PHASE3CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions
Gonorrhea
Interventions
DRUG

Ertapenem 1000 MG

single dose 1000mg intramuscular injection

DRUG

Fosfomycin Oral Suspension

single dose 6g oral suspension

DRUG

Gentamicin Sulfate, Injectable

single dose 5mg/kg (maximum 400mg) intramuscular injection

DRUG

Ceftriaxone

single dose 500mg intramuscular injection

Trial Locations (1)

1018WT

Public Health Service, Amsterdam

All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

Public Health Service of Amsterdam

OTHER_GOV

NCT03294395 - New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea | Biotech Hunter | Biotech Hunter